A tweet and a chart to think about.
Was traveling in midwest y'day to see ISI clients. Huge generalist interest in biotech & pharma right now. I mean off the charts.Mark Schoenebaum (@MarkSchoenebaum) February 20, 2014
There are several reasons why Celgene should buy Biogen.
CEOs of troubled companies tend to launch public tirades against the 'evil' shorts. The rants are often a smokescreen meant to divert investors' attention from problems.